Literature DB >> 2153898

Day-night variation in prepro vasoactive intestinal peptide/peptide histidine isoleucine mRNA within the rat suprachiasmatic nucleus.

H E Albers1, E G Stopa, R T Zoeller, J S Kauer, J C King, J S Fink, H Mobtaker, H Wolfe.   

Abstract

Neurons within the suprachiasmatic nuclei of the hypothalamus (SCN) appear to function as a circadian clock that controls the timing of many physiological systems. The SCN contain several chemically distinct neuronal subpopulations, including a large group of interneurons within the ventrolateral SCN that exhibit co-localizable immunoreactivity for both vasoactive intestinal peptide (VIP) and peptide histidine isoleucine (PHI). The purpose of the present study was to determine whether VIP/PHI neurons within the rat SCN exhibit rhythmicity in the cellular levels of the messenger RNA encoding the precursor from which both VIP and PHI are derived. Using both quantitative in situ and solution hybridization prepro-VIP/PHI mRNA levels early in the dark phase were demonstrated to be significantly higher than those 5 h after the onset of the daily light period. Since no statistically reliable (P greater than 0.05) day-night variation was observed in the levels of prepro-VIP/PHI mRNA within cortex, these data suggest that the rhythmicity in prepro-VIP/PHI mRNA is an intrinsic property of VIP/PHI-containing SCN neurons, or rhythmically driven by local synaptic events within the SCN.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153898     DOI: 10.1016/0169-328x(90)90077-q

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  24 in total

1.  Overexpression of the human VPAC2 receptor in the suprachiasmatic nucleus alters the circadian phenotype of mice.

Authors:  S Shen; C Spratt; W J Sheward; I Kallo; K West; C F Morrison; C W Coen; H M Marston; A J Harmar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

2.  Development of vasoactive intestinal peptide mRNA rhythm in the rat suprachiasmatic nucleus.

Authors:  Y Ban; Y Shigeyoshi; H Okamura
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

3.  Chronic stimulation of the hypothalamic vasoactive intestinal peptide receptor lengthens circadian period in mice and hamsters.

Authors:  Harry Pantazopoulos; Hamid Dolatshad; Fred C Davis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-05-12       Impact factor: 3.619

4.  The effects of aging and chronic fluoxetine treatment on circadian rhythms and suprachiasmatic nucleus expression of neuropeptide genes and 5-HT1B receptors.

Authors:  Marilyn J Duncan; James M Hester; Jason A Hopper; Kathleen M Franklin
Journal:  Eur J Neurosci       Date:  2010-05       Impact factor: 3.386

5.  Neuropeptide-mediated calcium signaling in the suprachiasmatic nucleus network.

Authors:  Robert P Irwin; Charles N Allen
Journal:  Eur J Neurosci       Date:  2010-10-12       Impact factor: 3.386

Review 6.  Light, immediate-early genes, and circadian rhythms.

Authors:  J M Kornhauser; K E Mayo; J S Takahashi
Journal:  Behav Genet       Date:  1996-05       Impact factor: 2.805

Review 7.  Regulation of VIP gene expression in general. Human lung cancer cells in particular.

Authors:  A Davidson; T W Moody; I Gozes
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

8.  GABA and glutamate mediate rapid neurotransmission from suprachiasmatic nucleus to hypothalamic paraventricular nucleus in rat.

Authors:  M L Hermes; E M Coderre; R M Buijs; L P Renaud
Journal:  J Physiol       Date:  1996-11-01       Impact factor: 5.182

9.  Changes in vasoactive intestinal peptide and arginine vasopressin expression in the suprachiasmatic nucleus of the rat brain following footshock stress.

Authors:  Robert J Handa; R Thomas Zoeller; Robert F McGivern
Journal:  Neurosci Lett       Date:  2007-08-25       Impact factor: 3.046

10.  Population encoding by circadian clock neurons organizes circadian behavior.

Authors:  Christopher M Ciarleglio; Karen L Gamble; John C Axley; Benjamin R Strauss; Jeremiah Y Cohen; Christopher S Colwell; Douglas G McMahon
Journal:  J Neurosci       Date:  2009-02-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.